A native of Sweden, Dr. Davidson specialties include organ procurement, organ transplantation, and dialysis access in end stage renal disease patients, with published educational books on these topics. Dr. Davidson initiated and maintains a development of several clinical activities, most notably an online training programs in dialysis access www.KidneyAcademy.com and is a co-investigator for NIH grant supported clinical dialysis access studies. 

Ms. Brouwer-Maier has worked in various aspects of acute and chronic nephrology nursing for over thirty-five years. Her area of focus in hemodialysis vascular access includes membership on the KDOQI VA Guideline Work Groups (1997, 2000, 2006), various Fistula First Work Groups, and nephrology nurse roles related to vascular access care.

Ms. Dillavou is an associate professor of vascular surgery at Duke University Medical Center and the Chief of Vascular Surgery at Duke Regional Hospital.  She earned a BA at Macalester College in St. Paul, MN, an MD at the University of Arizona, completed general surgery training at Thomas Jefferson University of Philadelphia and a vascular surgery fellowship at The University of Pittsburgh Medical Center. Her work centers on treatment of all facets of venous disease as well as complicated dialysis access.

In the field of dialysis access, Dr. Gallieni, a nephrologist in Milan Italy, is the Coordinating Editor of the Journal of Vascular Access, a leading publication in the field. He has been involved with the Vascular Access Society since 2009 (President, 2013-2015). He is an advocate of peritoneal dialysis.

Ms. Gedney is Vice President of Home Dialyzor’s United (@HDUorg). Active on the Policy and Advocacy Committee, she has spoken at numerous events including the Alliance for Home Dialysis, American Kidney Fund, National Kidney Foundation, SONG, Annual Dialysis Conference, The Kidney Project and Kidney Health Initiative (KHI). She is a contributor at Kidney Views Blog, CJASN, and Seminars in Nephrology.

Dr. Gibbs was appointed as a vascular and renal transplant surgeon in the Wessex Kidney Centre, Queen Alexander Hospital, Portsmouth. He serves as the Clinical Director of the Renal Transplant Program (2004 to 2018), is Clinical Lead for Vascular Access and an active trainer for both undergraduate and postgraduate trainees. He is now Care Group Director for general surgery.

Mr. Gilbert is a Consultant Transplant and Vascular Access Surgeon at the Oxford University Hospitals NHS Trust in the UK and was appointed in 2010. He is a specialist in Kidney & Pancreas Transplantation and Vascular access surgery and has a particular interest and expertise in complex re-do and salvage access surgery and access in patients with central vein pathology. Mr. Gilbert is the clinical lead for access within the organization and is currently president of VASBI. Mr. Gilbert is an educationalist and has a Masters in Education. He is heavily involved with undergraduate and postgraduate training. He is currently a clinical lecturer at Christ Church College, Oxford and is one of the Trust’s leads for education. Mr. Gilbert was responsible for the development of surgical educational supervisors across Health Education Thames Valley and is currently the Training Programme Director for Core Surgery training.

Dr. Hanko is a consultant nephrologist working in Belfast, Northern Ireland (UK). She has a subspecialty interest in vascular access which was initially developed during a fellowship with the University of British Columbia at Vancouver General Hospital. She is currently secretary of the Vascular Access Society of Northern Ireland.

Prof. Haskal has led, participated in, lectured upon and published hemodialysis-related research for 25 years. His pivotal studies defined the role of stent grafts in access preservation. Dr. Haskal has published over 400 peer-reviewed papers, editorial, abstracts, letters, and books and given over 500 invited lectures worldwide. He is the Emeritus Editor in Chief of the JVIR (2011-2020).

Dr. Hedin did his PhD in vascular cell biology, trained in vascular surgery at Karolinska University Hospital and University of Washington. He is leading an independent research group with a focus on carotid disease and has also a strong clinical focus on vascular access and was the co-founder of the Swedish Vascular Access meeting, a bi-annual national transdisciplinary effort to improve national access care since 2008. Dr. Hedin was appointed professor in 2003, holds the academic chair of vascular surgery since 2005 and is senior consultant in vascular surgery at Karolinska.

Mr.  Inston has been a consultant surgeon with an interest in transplantation and vascular access since 2008. Based in the University Hospital Birmingham he has a high volume practice in all aspects of surgery associated with renal failure. Following the award of a PhD in 2006 he has maintained  a range of academic interests in both vascular access and transplantation and has published in both fields. A past president of VASBI, council member of VAS and has been faculty for many meetings. In addition he acts as Clinical Director of Transplant Links Community, a charity developing transplant programs throughout the world.

Dr. Khan serves as the Director of Medical Services, NKF Singapore.  He is also a Senior Consultant at National University Hospital Singapore as well as Assistant Professor at National University Singapore. Dr. Khan is an interventional nephrologist and participates in both direct patient care and Kidney Health Advocacy programs in Singapore.

Dr. Lee is a medical officer on the Vascular and Endovascular Devices Team in the Office of Cardiovascular Devices, Center for Devices & Radiologic Health, US Food and Drug Administration. The Vascular and Endovascular Devices Team has the responsibility over the total product lifestyle for many of the medical devices used to create dialysis access with fistulas or prosthetic grafts, or to treat the venous stenosis that is the bane of angioaccess providers and patients. Prior to joining the FDA in 2015, he practiced vascular and endovascular surgery in southeast Michigan for three decades, where providing access for hemodialysis was a significant component of his clinical activity. 

A dedicated patient advocate; her husband Bill prior to his death a few years ago celebrated 46 years of renal replacement therapy.  He was one of the 4 patients who testified for House Ways and Means with one of them dialyzing before members of congress to pass Medicare legislation for ESRD. Ms. Litchfield has served on the KHI Patient and Family Partnership Council and AAKP to name a few of her patient advocacy roles.  As the care partner during home dialysis or supportive of in center care, she well knows the impact of kidney disease on a family.  Her background in Hospital Administration at some of the best-known tertiary institutions in the US, give her a unique background in health services and program planning. She currently is President of Access Solutions, an advocacy group focused on dialysis vascular access.

Since 2011, Dr. Ross has served as the Medical Director of Dialysis Access Institute at Regional Medical Center in Orangeburg, South Carolina. Prior to this, he was the Chief of Surgery from 1979-2011 at Bamberg County Hospital in Bamberg, South Carolina. He is the Recipient of Life Achievement Award 2015, The American Society of Interventional and Diagnostic Nephrology Certification.

​

In addition to being an active transplant nephrologist, Dr. Roy-Chaudhury’s main research
interest is in uremic vascular biology (including both dialysis vascular access dysfunction and
cardiovascular complications in kidney disease patients). Dr. Roy-Chaudhury has been the
recipient of extensive NIH research grant funding, has received national and international
awards, has published over 200 papers, and is a sought after invited speaker, both nationally
and internationally. Dr. Roy-Chaudhury has also been actively involved in the public policy and administrative aspects of dialysis vascular access care and hemodialysis through leadership roles in multiple societies such as ASN, ASDIN and VASA and is a Past President of the American Nephrologists of Indian Origin (ANIO). Dr. Roy-Chaudhury was also the founding ASN co-chair of the Kidney Health Initiative, a public-private partnership between ASN and the US FDA, and is currently a member of the steering committee for the Kidney X innovation accelerator which is a public-private partnership between ASN and the US Department of Health and Human Services.

Dr. Snoeijs' clinical and scientific interests are vascular access surgery and kidney transplantation. Maastricht UMC+ is the national referral center for complex vascular access surgery of which Dr. Snoeijs is the clinical lead. In addition, he trained as a clinical epidemiologist.

Dr. Swinnen serves as a Vascular Surgeon and a Dialysis Access Specialist at Westmead Hospital in Sydney, Australia. He is a certified Sonographer (DDU Vascular) and runs the Westmead Vascular Ultrasound Lab. He is Professor of Surgery at Sydney University and involved in clinical research.

Dr. Vin is a surgeon with Interventional Radiology training. Her practice focuses on the creation and maintenance (surgical and percutaneous) of the dialysis access. She leads the Dialysis Access Center at her institution, a multidisciplinary initiative that includes Nephrology Interventional Radiology, and Surgery, that offers patients outpatient maintenance of their dialysis access, reducing the burden endured due to their chronic disease.